The trends of lung cancer burden in BRICS from 1990 to 2021 and its projection to 2035
Frontiers in Oncology · 03.01.2025 · 14
DOI: 10.3389/fonc.2024.1511530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 03.01.2025. Verfasst von Yifan Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lung cancer has become the malignant tumor with the highest morbidity and mortality in the world. This study aims to analyze the burden of lung cancer and risk factors associated with lung cancer in the BRICS from 1990-2021 and to project the burden of lung cancer in the BRICS from 2021-2035.
Methods
The Global Burden of Disease (GBD) 2021 database was searched to collect the incidence, prevalence, mortality, disability-adjusted life years (DALYs), and risk factors of lung cancer in the BRICS. Trends in lung cancer burden from 1990-2021 were analyzed using Joinpoint 4.9.1.0, and Bayesian age-period-cohort (BAPC) analyses were performed using R4.4.1 to project the disease burden of lung cancer from 2021-2035.
Results
AAPC(average annual percentage change) and EAPC(estimated average percentage change) of ASIR(age-standardized incidence), ASPR(age-standardized prevalence), ASMR(age-standardized mortality), and ASDR(age-standardized disability-adjusted life year) for lung cancer in Brazil, Russia, and Ethiopia 1990-2021 were less than 0. Egypt’s AAPC and EAPC for ASIR, ASPR, ASMR, and ASDR were all greater than 0 for 1990-2021, and China’s ASIR, ASPR, ASMR, and ASDR were all at the top of the BRICS in 2021. According to BAPC projection Brazil, Iran, Russia, and South Africa will have a decreasing trend in ASIR, ASPR, ASMR, and ASDR from 2021-2035. Egypt will have an increasing trend in ASIR, ASPR, ASMR, and ASDR from 2021-2035. With the exception of Ethiopia, the top tier level 1 and level 2 risk factors in the rest of the BRICS were behavioral factors and smoking factors, respectively.
Conclusion
The BRICS still have a heavy burden of lung cancer, and there are significant differences in the burden of lung cancer among the BRICS. At the same time, many BRICS lung cancer prevention and control measures are worth learning from other developing countries.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, China.
- The Fourth Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, China.
- The Information and Control Engineering College of Qingdao University of Technology, Qingdao, China.
Zitieren
APA
Wang, Y., Zhu, J., Wang, S., & Zhou, J. (2025). The trends of lung cancer burden in BRICS from 1990 to 2021 and its projection to 2035. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1511530
Vancouver
Wang Y, Zhu J, Wang S, Zhou J. The trends of lung cancer burden in BRICS from 1990 to 2021 and its projection to 2035. Frontiers in Oncology. 2025;14. doi:10.3389/fonc.2024.1511530
BibTeX
@article{Wang2025,
author = {Wang, Yifan and Zhu, Jingwen and Wang, Shaoqiang and Zhou, Jihong},
title = {The trends of lung cancer burden in BRICS from 1990 to 2021 and its projection to 2035},
journal = {Frontiers in Oncology},
year = {2025},
volume = {14},
doi = {10.3389/fonc.2024.1511530}
}
EUVIMED